(a MEE no le vue lih nick) Brand: Levulan Kerastick
• Only a qualified doctor or another healthcare professional must apply aminolevulinic acid. Aminolevulinic acid is not intended for application by the patient.
• After aminolevulinic acid has been applied, wear sunlight-protective clothing such as a wide-brimmed hat or similar head covering. Sunscreens will not protect you. Avoid exposure to sunlight or bright indoor easy (examination lamps, operating room lamps, tanning beds, or very close lights). If you experience stinging or burning of the treated skin, reduce your exposure to easy. It has not been certain if perspiration can spread aminolevulinic acid external the treatment site to the eyes or surrounding skin.
• Aminolevulinic acid causes skin cells to become many more sensitive to determined types of easy. Skin cells treated with aminolevulinic acid and exposed to a particular easy die and then slough off.
• Aminolevulinic acid is used to treat warty overgrowths of skin (actinic keratoses) on sun-exposed areas of the person and scalp. Treatment involves application of aminolevulinic acid, followed 14 to 18 hours later by exposure to a particular blue light.
• Aminolevulinic acid may also be used for purposes another than those listed in this medicine guide.
• Till using aminolevulinic acid, speak your doctor if you have
· porphyria, or
· a bleeding or blood clotting disorder.
• You may not be able to use aminolevulinic acid, or you may require a dosage adjustment or particular monitoring during your treatment.
• Aminolevulinic acid is the FDA pregnancy category C. This means that it is not known whether aminolevulinic acid will harm an unborn child. Do not use aminolevulinic acid without first talking to your doctor if you are pregnant.
• It is unknown whether aminolevulinic acid passes into breast milk. Do not use aminolevulinic acid without first talking to your doctor if you are breast feeding a baby.
• Only a qualified doctor or another healthcare professional must apply aminolevulinic acid. Aminolevulinic acid is not intended for application by the patient.
• Your doctor or another health care professional will prepare the aminolevulinic acid solution in the applicator. Aminolevulinic acid solution application will be completed within 2 hours of preparation.
• Application of aminolevulinic acid involves either scalp or person lesions, but not both at the same time. It will be applied directly to the individual areas and not to the surrounding skin.
• After aminolevulinic acid has been applied, wear sunlight-protective clothing such as a wide-brimmed hat or similar head covering. Sunscreens will not protect you. Avoid exposure to sunlight or bright indoor easy (examination lamps, operating room lamps, tanning beds, or very close lights). If you experience stinging or burning of the treated skin, reduce your exposure to easy. It has not been certain if perspiration can spread aminolevulinic acid external the treatment site to the eyes or surrounding skin.
• Fourteen to eighteen hours after application of aminolevulinic acid, you should return to the doctor's office to receive a particular blue easy treatment. Prior to the blue easy treatment, the lesions will be rinsed with water. You will be given particular goggles to wear during the treatment which will recent about 17 minutes. The blue easy is of low intensity and will not heat the skin. However, you may experience tingling, stinging, prickling, or burning of the treated skin. These feelings of discomfort must improve at the end of the easy treatment.
• Next the treatment, you will experience some redness, swelling, and scaling of the lesions, and to some degree, the surrounding skin. These changes are temporary and must completely resolve by 4 weeks after treatment. If these side effects are overweening, conversation to your doctor.
• Aminolevulinic acid and easy treatment is generally done once to every area with lesions. The procedure may be repeated after 8 weeks on lesions that have not completely resolved.
• Store aminolevulinic acid at room temperature away from moisture and heat.
• If for any cause you can't return for the blue easy treatment during the predesigned period of time after application of the aminolevulinic acid solution, call your doctor. Also, continue to avoid exposure of the treated areas to sunlight or prolonged or intense easy for at least 40 hours. If you experience stinging or burning of the treated area(s), reduce your exposure to light.
• An overdose of this medicine is unlikely to occur. If you do suspect an overdose, or if aminolevulinic acid has been ingested, call an abnormal room or poison control center around you. Avoid exposure to intense easy sources for at least 40 hours.
• After aminolevulinic acid has been applied, wear sunlight-protective clothing such as a wide-brimmed hat or similar head covering. Sunscreens will not protect you. Avoid exposure to sunlight or bright indoor easy (examination lamps, operating room lamps, tanning beds, or very close lights). If you experience stinging or burning of the treated skin, reduce your exposure to easy. It has not been certain if perspiration can spread aminolevulinic acid external the treatment site to the eyes or surrounding skin.
• Serious side effects are not likely to occur. Stop using aminolevulinic acid and search abnormal medical attention if you experience an allergic reaction (shortness of breath; closing of your throat; swelling of your lips, person, or tongue; or hives).
• You may experience some tingling, stinging, prickling, or burning of the area treated with aminolevulinic acid during the particular easy treatment. These feelings of discomfort must improve at the end of the easy treatment. Next treatment, you will experience some redness, swelling, and scaling of the lesions, and to some degree, the surrounding skin. These changes are temporary and must completely resolve by 4 weeks after treatment. If these side effects are overweening, conversation to your doctor.
• Side effects another than those listed here may also occur. Conversation to your doctor about any side effect that seems unusual or that is especially bothersome. You may message side effects to FDA at 1-800-FDA-1088.
• Till treatment with aminolevulinic acid, speak your doctor if you are taking any another medicines, especially any of the following:
· griseofulvin (Fulvicin, Grifulvin, Grisactin, others);
· an oral diabetes medication such as glimepiride (Amaryl), glipizide (Glucotrol), glyburide (Diabeta, Micronase, Glynase, others), tolbutamide (Orinase), and others;
· a phenothiazine including chlorpromazine (Thorazine), fluphenazine (Prolixin), perphenazine (Trilafon), mesoridazine (Serentil), thioridazine (Mellaril), and others;
· a sulfa drug (sulfonamide) such as sulfamethoxazole (Gantanol, others), sulfamethoxazole and trimethoprim (Bactrim, Cotrim, Septra, Septra DS, others), sulfisoxazole (Gantrisin), and others;
· a tetracycline antibiotic such as tetracycline (Sumycin, Achromycin), minocycline (Minocin), doxycycline (Monodox, Doryx, Vibramycin, Vibra-Tabs), and others; or
· a diuretic (water pill) such as hydrochlorothiazide (HCTZ, HydroDiuril, Esidrix, Oretic, Microzide, others), chlorthalidone (Hygroton, Thalitone), chlorothiazide (Diuril), indapamide (Lozol), metolazone (Mykrox, Zaroxolyn), and others.
• You may not be able to use aminolevulinic acid, or you may require a dosage adjustment or particular monitoring during treatment if you are taking any of the medicines listed above.
• Drugs another than those listed here may also interact with aminolevulinic acid. Conversation to your doctor and pharmacist till taking any prescription or over-the-counter medicines.
• Your pharmacist has additional information about aminolevulinic acid written for health professionals that you may read.
Remember, hold this and all another medicines out of the reach of children, never share your medicines with others, and use this medicine only for the indication prescribed.
Disclaim: Each effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses external of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way must be construed to indicate that the drug or drug combination is safety, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the help of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.